Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number:
Register
171 - Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee)
Type: Roundtables
Date/Time: Tuesday, August 10, 2021 : 12:00 PM to 1:20 PM
Sponsor: Biopharmaceutical Section
Abstract #317593
Title: Improving Precision and Power in Randomized Trials Using Covariate Adjustment
Author(s): Michael Rosenblum* and Bingkai Wang and Alex Luedtke and David Benkeser and Ivan Diaz and Daniel Scharfstein and Jodi Seagal
Companies: Johns Hopkins University and Johns Hopkins Bloomberg School of Public Health and University of Washington and Emory University and Weill Cornell Medical College and University of Utah and Johns Hopkins University
Keywords: clinical trial; model robust; regulatory science
Abstract:

In randomized clinical trials with baseline variables that are correlated with the outcome, there is potential to substantially improve precision and reduce the required sample size by appropriately adjusting for these variables in the statistical analysis (called covariate adjustment). Despite regulators such as the U.S. Food and Drug Administration and the European Medicines Agency recommending covariate adjustment, it remains highly underutilized leading to inefficient trials in many disease areas. This is especially true for trials with binary, ordinal, and time-to-event outcomes, which are quite common. We discuss how to implement covariate adjustment in the context of several disease areas including: COVID-19 treatment trials, Alzheimer's disease trials, and stroke treatment trials. We also discuss new estimators that leverage precision gains from both stratified randomization and covariate adjustment.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2021 program